Domino’s Pizza: results out Thursday. Photograph: REUTERS/Luke MacGregor
For your diary

TODAY Results: Hasbro; M&T Bank; Morgan Stanley; Sanmina. Indicators: Euro zone construction output (Feb); US Chicago Fed national activity index (...)

Pfizer and Eli Lilly will resume a late-stage study testing their pain drug tanezumab after the US Food and Drug Administration lifted a partial hold (...)

Biogen’s market value has risen by $45 billion to nearly $110 billion in a little over a year

An experimental Alzheimer’s drug being developed by a US biotech group has offered hope that scientists may be closer to a breakthrough for the devast(...)

GSK is forming a consumer health joint venture with Novartis, while at the same time buying the Swiss company’s vaccines business and divesting its cancer drugs portfolio to Novartis

GlaxoSmithKline and Novartis said on Monday they had completed a series of asset swaps worth more than $20 billion that will reshape both drugmakers.G(...)

Microsoft: results today. Photograph: Justin Sullivan/Getty Images
For your diary

TODAY Results: Crane; Microsoft; Sanmina. Meetings: Hostelworld conference (Convention Centre Dublin). Indicators: Euro zone retail sales (D(...)

Kinsale has a great deal going for it. By the sea, it has a reputation as the gourmet capital of Ireland. It is a postcard-pretty village in the he(...)

EU antitrust regulators have approved US drugmaker Eli Lilly’s $5.4 billion takeover of Swiss peer Novartis’s animal health business. Photo: Reuters

EU antitrust regulators approved US drugmaker Eli Lilly’s $5.4 billion takeover of Swiss peer Novartis’s animal health business on Friday.The Europea(...)

Joe Jimenez: refocusing Novartis on pharmaceuticals, eyecare and generics

A near $50 billion (€36 billion) takeover battle for the maker of Botox and a multibillion-dollar asset swap between Novartis and Glaxo-SmithKline (...)

AstraZeneca shares surged by 8 per cent at one stage amid frenzied speculation that US rival Pfizer was preparing a mega-bid. Photograph: Chris Ratcliffe/Bloomberg

A flurry of deals and speculation of more to come has set the pharmaceuticals sector alight, sending shares in some of the UK’s biggest drugs g(...)

Eli Lilly said the deal is not expected to change its dividend policy or current share repurchase programme

Eli Lilly has confirmed it will buy Swiss drugmaker Novartis AG’s animal health business for $5.4 billion in cash to strengthen and diversify (...)